about
CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1Cholesterol metabolism is required for intracellular hedgehog signal transduction in vivoNovel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in SchizophreniaGenetic relationship between five psychiatric disorders estimated from genome-wide SNPsGenome-wide association analysis identifies 13 new risk loci for schizophreniaClonal hematopoiesis and blood-cancer risk inferred from blood DNA sequenceMosaic copy number variation in schizophreniaThe IFT-A complex regulates Shh signaling through cilia structure and membrane protein traffickingGenome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorderA forward genetic screen with a thalamocortical axon reporter mouse yields novel neurodevelopment mutants and a distinct emx2 mutant phenotype.Concurrent Lpin1 and Nrcam mouse mutations result in severe peripheral neuropathy with transitory hindlimb paralysis.De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.High resolution mapping and positional cloning of ENU-induced mutations in the Rw region of mouse chromosome 5.Genome-wide identification of mouse congenital heart disease loci.A polygenic burden of rare disruptive mutations in schizophrenia.Utilization of a whole genome SNP panel for efficient genetic mapping in the mouse.The penetrance of copy number variations for schizophrenia and developmental delay.A spontaneous Fatp4/Scl27a4 splice site mutation in a new murine model for congenital ichthyosisDe novo mutations in schizophrenia implicate synaptic networksDe novo CNVs in bipolar affective disorder and schizophrenia.Copy number variation in schizophrenia in SwedenAnalysis of genetic deletions and duplications in the University College London bipolar disorder case control sample.De novo exon duplication in a new allele of mouse Glra1 (spasmodic)Focusing forward genetics: a tripartite ENU screen for neurodevelopmental mutations in the mouseENU mutagenesis in mice identifies candidate genes for hypogonadismzCall: a rare variant caller for array-based genotyping: genetics and population analysis.No evidence for rare recessive and compound heterozygous disruptive variants in schizophrenia.Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depthPolymorphisms in toll-like receptor 4 underlie susceptibility to tumor induction by the mouse polyomavirus.Agouti C57BL/6N embryonic stem cells for mouse genetic resourcesExome arrays capture polygenic rare variant contributions to schizophrenia.Evidence of Common Genetic Overlap Between Schizophrenia and Cognition.Exome sequencing and the genetic basis of complex traitsThe genomic psychiatry cohort: partners in discovery.Implication of a rare deletion at distal 16p11.2 in schizophrenia.Common alleles contribute to schizophrenia in CNV carriers.Polygenic overlap between schizophrenia risk and antipsychotic response: a genomic medicine approach.Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorderCopy number variation in bipolar disorder.An N-ethyl-N-nitrosourea mutagenesis recessive screen identifies two candidate regions for murine cardiomyopathy that map to chromosomes 1 and 15.
P50
Q24603800-4B8B241C-2282-491B-8C5A-7CCCE7C6163DQ27339142-472F4706-E79D-4A2C-B395-903C6C27DE4DQ28262977-4E795FAD-AC5F-4C50-8AC9-4CA92DFCEA31Q28296286-91427366-250C-4BB5-9BC1-CDE1EB44F162Q28297287-92F62A39-2BA3-41D2-82C2-C55228F1C402Q28385712-CD1B55FF-A804-4092-9AD4-0A75D27DC214Q28387422-904151E7-BE60-4C5E-A603-DD40F947AB22Q28506316-D7562C53-12A6-4171-9FA0-EA21CC0B6752Q28943293-85393AC0-D0E2-4A69-84FD-2E05E8C0B681Q30433445-9FB6E223-3CDB-40E7-A2B6-9E934C4A5896Q30491463-59C30C53-8910-4B2D-959F-A9CC44308D5CQ33398247-449A088B-EF37-403F-A10F-CBF32E7C4AB1Q33759166-2E4DDF89-05B5-4C1A-8313-1F223E76CBD9Q34013514-F75D2B6E-8CED-43D7-A495-3BC22A3CFD2FQ34060200-94C380E3-C857-4017-AB49-756B2B1D0A26Q34483116-0F596557-8D4A-41BD-BC3D-0FE11B62013CQ34497136-93294A73-36C9-4AF9-A391-C8E27C1CDD4AQ34505676-A9C1B4FC-3C52-4A67-9424-4A9748F44AD8Q34540372-FBD614E7-8F7B-4DAA-BAB3-2AF35D103D8DQ34555512-134B8A7C-CC03-48F1-B623-903D4FBDED78Q34742638-5F6B0943-0DC9-49F6-A86A-67658244224BQ34873753-7AB1B989-82D7-435F-BF02-7FCB2176AFA0Q35221560-59C319BE-D3CB-4833-8CC3-334EC1B3A424Q35222725-64961570-6AA2-4A20-897C-9FE5C5F9B51BQ35981426-BF6E5166-FA57-41F6-94CF-884A5528BE46Q36294014-7582F6E8-914D-4C92-BC47-456FB1825E39Q36338214-B798266B-3721-4821-AD71-8BFD7AAE785DQ36358463-78625F15-74B5-49A9-85B1-1C6549C811D9Q36363286-3BDB7EAB-ACA9-42AC-9B8D-36388D66F92BQ36562560-7AFAD899-26AD-4843-B6CF-D7BA7F4111E5Q36581392-3281927B-2F83-44F8-9561-4892BA118615Q36817198-C1C93FF8-DEDB-4365-86D2-DE6C371FC6CEQ37056084-775A7524-5964-4640-9761-F71DCDBB21FBQ37059547-DC801D21-708C-4264-85B2-59FEBFD28DECQ37114489-ED07538A-799E-4A86-B375-DF32F1886CD6Q37124986-1164934B-65A8-4B7A-8AFF-BC8C756F7A9FQ37170587-59609C77-E27F-4904-8271-0727085438BFQ37199024-2C543F26-B0D4-4205-B00C-56A89530F6B8Q37287371-C6373A41-2090-4843-B7AE-134A9FEBE12FQ37346678-B112983D-EB0F-4902-9E25-37E0ED712ABB
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Jennifer L Moran
@nl
Jennifer L Moran
@sl
Jennifer L. Moran
@en
Jennifer L. Moran
@es
type
label
Jennifer L Moran
@nl
Jennifer L Moran
@sl
Jennifer L. Moran
@en
Jennifer L. Moran
@es
altLabel
J L Moran
@en
Jennifer Moran
@en
prefLabel
Jennifer L Moran
@nl
Jennifer L Moran
@sl
Jennifer L. Moran
@en
Jennifer L. Moran
@es
P106
P1153
12762538800
55928550900
P21
P2798
P31
P496
0000-0002-5664-4716